Suppr超能文献

氟喹诺酮类、大环内酯类和氨基糖苷类药物与糖基化、脂肪酸及肽生物合成抑制剂联合应用对鸟分枝杆菌的活性

Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.

作者信息

Barrow W W, Wright E L, Goh K S, Rastogi N

机构信息

Department of Microbiology and Immunology, Texas College of Osteopathic Medicine, Fort Worth 76107.

出版信息

Antimicrob Agents Chemother. 1993 Apr;37(4):652-61. doi: 10.1128/AAC.37.4.652.

Abstract

Smooth- and rough-colony variants of Mycobacterium avium serovar 4 were treated with three classes of drugs. The drugs were chosen for their potential inhibitory effects on the biosynthesis of the cell envelope-associated serovar-specific glycopeptidolipid antigens. Growth was monitored radiometrically with a BACTEC 460-TB instrument, and MICs were determined for each drug. Both variants were then treated with inhibitory drugs in combination with antimicrobial agents that have demonstrated effectiveness against M. avium. No growth inhibition was observed with 6-fluoro-6-deoxy-D-glucose or avidin. Inhibitors of glycosylation, i.e., 2-deoxy-D-glucose, bacitracin, and ethambutol, were inhibitory to smooth- and rough-colony variants, whereas drugs that inhibit peptide synthesis, i.e., N-carbamyl-L-isoleucine and m-fluoro-phenylalanine, were more inhibitory for the rough-colony variant. Cerulenin, which affects fatty acid synthesis, was inhibitory for both variants, but it appeared to be more effective at inhibiting the growth of the smooth-colony variant at equivalent concentrations. Generally, when inhibitors of glycosylation were used with sparfloxacin and amikacin, a synergistic effect was observed for only the smooth variant. When drugs that affect peptide synthesis were used in combination with amikacin, a synergistic effect was observed for the rough variant, and when cerulenin was used in combination with sparfloxacin or amikacin, a synergistic effect was observed for both variants. Lipid analysis revealed that although the rough variant lacks the serovar-specific glycopeptidolipid antigens, it does possess a group of phenylalanine-isoleucine-containing lipopeptides that may explain its different susceptibility patterns to m-fluoro-phenylalanine and N-carbamyl-L-isoleucine. The significance of these results is discussed with reference to various components in the cell envelope and their importance in cell wall permeability.

摘要

鸟分枝杆菌血清型4的光滑菌落和粗糙菌落变体用三类药物进行处理。选择这些药物是因其对与细胞包膜相关的血清型特异性糖肽脂抗原生物合成具有潜在抑制作用。使用BACTEC 460-TB仪器通过放射测量法监测生长情况,并测定每种药物的最低抑菌浓度(MIC)。然后将两种变体用抑制性药物与已证明对鸟分枝杆菌有效的抗菌剂联合处理。6-氟-6-脱氧-D-葡萄糖或抗生物素蛋白未观察到生长抑制作用。糖基化抑制剂,即2-脱氧-D-葡萄糖、杆菌肽和乙胺丁醇,对光滑菌落和粗糙菌落变体均有抑制作用,而抑制肽合成的药物,即N-氨甲酰-L-异亮氨酸和间氟苯丙氨酸,对粗糙菌落变体的抑制作用更强。影响脂肪酸合成的蜡黄霉素对两种变体均有抑制作用,但在同等浓度下,它似乎对光滑菌落变体的生长抑制更有效。一般来说,当糖基化抑制剂与司帕沙星和阿米卡星联合使用时,仅在光滑变体中观察到协同作用。当影响肽合成的药物与阿米卡星联合使用时,在粗糙变体中观察到协同作用,当蜡黄霉素与司帕沙星或阿米卡星联合使用时,在两种变体中均观察到协同作用。脂质分析表明,尽管粗糙变体缺乏血清型特异性糖肽脂抗原,但它确实拥有一组含苯丙氨酸-异亮氨酸的脂肽,这可能解释了其对间氟苯丙氨酸和N-氨甲酰-L-异亮氨酸不同的敏感性模式。参照细胞包膜中的各种成分及其在细胞壁通透性中的重要性对这些结果的意义进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3e4/187730/a69b0893824d/aac00026-0065-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验